Accreditation/Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 7.0 Contact Hours.
Acknowledgment of Commercial SupportThis activity is supported by educational grants from AbbVie Inc., Astellas, Bayer, Ferring Pharmaceuticals Inc., Genomic Health, Inc., Medivation, Inc., Novartis Pharmaceuticals Corporation, and Sanofi US.
New York GU: 9th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies
Click here to download brochure
Crowne Plaza® Times Square Manhattan
1605 Broadway (at 49th Street)
New York, NY 10019
OverviewThe New York GU™: 9th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies is an intensive, interactive, one-day educational program that brings together renowned national experts in the fields of genitourinary malignancies treatment.
The Congress will focus on key clinical topics in the management of genitourinary malignancies, including prognostic/predictive markers in care, proactive methods to mitigate predictable treatment-related side effects, optimal use of chemotherapeutic strategies, androgen deprivation therapies, targeted therapies, radiopharmaceuticals, and immunotherapies, as well as exploring emerging data on various combinations and sequences of treatment strategies currently undergoing clinical trial evaluation. This year, there will be a particular and expanded focus on bladder cancer and renal cell carcinoma, given recent practice-changing developments that are altering the therapeutic landscape in these fields of care. Key questions concerning the application of landmark clinical trial data on emerging targeted and immunotherapeutic options, as well as the application of evolving biomarkers for these tumors, will be answered during expanded sessions on these topics this year.
This year's New York GU™ meeting is not to be missed! The program is sure to continue its legacy and tradition to provide clinicians with the knowledge and confidence to maintain state-of-the-art care, and optimize outcomes for patients with genitourinary malignancies.
Target AudienceThis educational activity is directed toward medical oncologists, radiation oncologists, surgeons, and urologists involved in the treatment and management of patients with prostate cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, and other health care professionals interested in the treatment of prostate cancer may also participate.
- Describe methods to stratify risk and tumor information that can provide the rationale for clinical decision-making in the management of genitourinary (GU) malignancies
- Summarize recommendations that shape current strategies to care for patients with GU malignancies
- Develop multidisciplinary strategies to optimize outcomes by proactive mitigation of known treatment-related side effects in caring for patients with GU malignancies
- Assess recent practice-changing clinical trial findings concerning novel compounds or strategies to manage GU malignancies
- Apply emerging clinical concepts to support the management of GU malignancies in consideration of evolving treatment paradigms in the field
Co-ChairsDaniel P. Petrylak, MD
Professor of Medicine, Medical Oncology
Director, Prostate and GU Medical Oncology
Director, Prostate Cancer Translational Research Program
Yale Cancer Center
New Haven, CT
Leonard G. Gomella, MD, FACS
The Bernard W. Godwin Professor of Prostate Cancer
Chairman, Department of Urology
Associate Director, Jefferson Kimmel Cancer Center
Clinical Director Jefferson Kimmel Cancer Center Network
Thomas Jefferson University
You must be logged in to PER to register for this meeting
Or Register for PER now
In case of onsite emergency:
Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19
I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventive measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities, including providing proof at check in of being 2 weeks removed from receiving a full COVID-19 vaccination or results from a negative COVID-19 viral test taken no more than 3 days prior to the program.
I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.
* By checking this box, you have read and understand the above and agree to its terms.